Frank J. Borm
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Correction to: Frequent, dual and nighttime nicotine use among Dutch adolescents: findings from a school-based survey.
Journal: European journal of pediatrics
Published: January 03, 2026
PD-1 blockade does not enhance alloimmunization after allogeneic dendritic cell vaccination in cancer patients.
Journal: Frontiers in immunology
Published: December 08, 2025
Frequent, dual and nighttime nicotine use among Dutch adolescents: findings from a school-based survey.
Journal: European journal of pediatrics
Published: August 13, 2025
Liquid biopsy in BALF is now suitable for clinical practice in patients with suspected NSCLC.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 23, 2025
Innovative therapeutic cancer vaccine PDC∗lung01 with or without anti-PD-1: an open-label, dose-escalation phase I/II study in non-small-cell lung cancer.
Journal: ESMO open
Published: May 27, 2025
Electronic Nicotine-Delivery Systems for Smoking Cessation.
Journal: The New England journal of medicine
Published: May 15, 2024
I will prevent disease whenever I can, for prevention is preferable to cure: doctors' role in the vaping epidemic.
Journal: European journal of pediatrics
Published: April 13, 2024
Poziotinib for HER2 Exon 20-Mutated NSCLC: Addition or Burden to the Therapeutic Arsenal?
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 01, 2023
Early response evaluation of PD-1 blockade in NSCLC patients through FDG-PET-CT and T cell profiling of tumor-draining lymph nodes.
Journal: Oncoimmunology
Published: May 01, 2023
Detection of Circulating Tumor Cells Using the Attune NxT.
Journal: International journal of molecular sciences
Published: November 09, 2022
Near-Infrared Fluorescence Tumor-Targeted Imaging in Lung Cancer: A Systematic Review.
Journal: Life (Basel, Switzerland)
Published: February 01, 2022
PD-L1 PET/CT Imaging with Radiolabeled Durvalumab in Patients with Advanced-Stage Non-Small Cell Lung Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: May 05, 2021
Last Updated: 09/26/2026